Literature DB >> 17764626

Type 2 diabetes and risk of cognitive impairment and dementia.

Rachel A Whitmer1.   

Abstract

Diabetes is a major public health burden. Even a modest effect of diabetes on cognitive function has significant public health implications. Several lines of mechanistic evidence implicate a role of insulin and glucose metabolism on risk of developing dementia, including Alzheimer's disease. Population-based studies have shown that those with type 2 diabetes mellitus have an increased risk of cognitive impairment, dementia, and neurodegeneration. There are many mechanisms through which diabetes could increase risk of dementia, including glycemia, insulin resistance, oxidative stress, advanced glycation endproducts, inflammatory cytokines, and microvascular and macrovascular disease. This paper presents a review of the evidence on diabetes and increased risk of dementia and cognitive impairment, a discussion of different possible mechanisms, and remaining gaps in our knowledge.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764626     DOI: 10.1007/s11910-007-0058-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  104 in total

1.  Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

Authors:  J Heitner; D Dickson
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

Review 2.  Cerebral microvascular pathology in aging and Alzheimer's disease.

Authors:  E Farkas; P G Luiten
Journal:  Prog Neurobiol       Date:  2001-08       Impact factor: 11.685

3.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

4.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

Authors:  M N Haan; L Shemanski; W J Jagust; T A Manolio; L Kuller
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

Review 5.  Glucose regulation and brain aging.

Authors:  C Messier; M Gagnon
Journal:  J Nutr Health Aging       Date:  2000       Impact factor: 4.075

6.  Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis.

Authors:  S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

7.  Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.

Authors:  Chris MacKnight; Kenneth Rockwood; Erin Awalt; Ian McDowell
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

8.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

9.  Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment.

Authors:  G J Biessels; A Kamal; I J Urban; B M Spruijt; D W Erkelens; W H Gispen
Journal:  Brain Res       Date:  1998-07-27       Impact factor: 3.252

10.  Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; F Javier Nieto; Lori L Boland; David J Couper; Thomas H Mosley; Barbara E K Klein; Larry D Hubbard; Moyses Szklo
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

View more
  70 in total

1.  Sex differences in the association of Framingham Cardiac Risk Score with cognitive decline in community-dwelling elders without clinical heart disease.

Authors:  Gail A Laughlin; Linda K McEvoy; Denise von Mühlen; Lori B Daniels; Donna Kritz-Silverstein; Jaclyn Bergstrom; Kevin Cummins; Claudia Der-Martirosian; Simerjot K Jassal; Elizabeth Barrett-Connor
Journal:  Psychosom Med       Date:  2011-09-23       Impact factor: 4.312

Review 2.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

Review 3.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

Review 4.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

5.  Cognitive function is a risk for health literacy in older adults with diabetes.

Authors:  Ha T Nguyen; Julienne K Kirk; Thomas A Arcury; Edward H Ip; Joseph G Grzywacz; Santiago J Saldana; Ronny A Bell; Sara A Quandt
Journal:  Diabetes Res Clin Pract       Date:  2013-06-24       Impact factor: 5.602

Review 6.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 7.  Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains.

Authors:  Priya Palta; Andrea L C Schneider; Geert Jan Biessels; Pegah Touradji; Felicia Hill-Briggs
Journal:  J Int Neuropsychol Soc       Date:  2014-02-20       Impact factor: 2.892

Review 8.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

9.  Pharmacological inhibition of mitochondrial carbonic anhydrases protects mouse cerebral pericytes from high glucose-induced oxidative stress and apoptosis.

Authors:  Gul N Shah; Tulin O Price; William A Banks; Yoichi Morofuji; Andrej Kovac; Nuran Ercal; Christine M Sorenson; Eui S Shin; Nader Sheibani
Journal:  J Pharmacol Exp Ther       Date:  2012-12-17       Impact factor: 4.030

10.  Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage.

Authors:  Jasmine Nettiksimmons; Laurel Beckett; Christopher Schwarz; Owen Carmichael; Evan Fletcher; Charles Decarli
Journal:  Psychol Aging       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.